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Abstract
A mutated KRAS protein is frequently observed in human cancers. Traditionally, the onco-
genic properties of KRAS missense mutants at position 12 (G12X) have been considered
as equal. Here, by assessing the probabilities of occurrence of all KRAS G12X mutations
and KRAS dynamics we show that this assumption does not hold true. Instead, our findings
revealed an outstanding mutational bias. We conducted a thorough mutational analysis of
KRAS G12X mutations and assessed to what extent the observed mutation frequencies fol-
low a random distribution. Unique tissue-specific frequencies are displayed with specific
mutations, especially with G12R, which cannot be explained by random probabilities. To
clarify the underlying causes for the nonrandom probabilities, we conducted extensive atom-
istic molecular dynamics simulations (170 μs) to study the differences of G12X mutations on
a molecular level. The simulations revealed an allosteric hydrophobic signaling network in
KRAS, and that protein dynamics is altered among the G12X mutants and as such differs
from the wild-type and is mutation-specific. The shift in long-timescale conformational
dynamics was confirmed with Markov state modeling. A G12X mutation was found to modify
KRAS dynamics in an allosteric way, which is especially manifested in the switch regions
that are responsible for the effector protein binding. The findings provide a basis to under-
stand better the oncogenic properties of KRAS G12X mutants and the consequences of the
observed nonrandom frequencies of specific G12X mutations.
Author summary
The oncogene KRAS is frequently mutated in various cancers. When the amino acid gly-
cine 12 is mutated, KRAS protein acquires oncogenic properties that result in tumor cell-
growth and cancer progression. These mutations prevail especially in the pancreatic
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ductal adenocarcinoma, which is a cancer with an exceptionally dismal prognosis. To
date, there is a limited understanding of the different mutations at the position 12, also
regarding whether the different mutations would have different consequences. These dis-
crepancies could have major implications for the future drug therapies targeting KRAS
mutant harboring tumors. In this study, we made a critical assessment of the observed fre-
quency of KRAS G12X mutations and the underlying causes for these frequencies. We
also assessed KRAS G12X mutant discrepancies on an atomistic level by utilizing state-of-
the-art molecular dynamics simulations. We found that the dynamics of the mutants does
not only differ from the wild-type protein, but there is also a profound difference among
the different mutants. These results emphasize that the different KRAS G12X mutations
are not equal, and thereby they suggest that the future research related to mutant KRAS
biology should account for these observations.
Introduction
The small GTPase protein KRAS is a signal-transducing protein, which binds GDP in its inac-
tive state and GTP in its active state [1]. The gene KRAS is frequently mutated in various
human cancers. The mutation is most often, in about 86% of the cases [2], found at G12. In
fact, every missense mutation at G12 (G12X) is oncogenic. The oncogenic properties associ-
ated with KRAS G12X mutation are characterized by the deficiency of the intrinsic GTPase
activity and the insensitivity for GTPase-activating proteins (GAPs) [3,4]. These alterations
lead to increased KRAS signaling, as there is more active GTP-bound protein present. Still, the
mutant KRAS undergoes GDP–GTP cycling [5]. The basis of the specific G12X mutation fre-
quencies has remained unclear, except for the G12C transversion mutation (c.34G>T) associ-
ated with smoking in lung cancer [6,7].
An interesting discrepancy among KRAS G12X mutants is observed in their intrinsic
GTPase activity [8]. The G12A mutation exhibits the most hindered intrinsic hydrolysis (~1%
compared to the wild-type), whereas the G12C mutation displays the least hindered activity
(~72%). All G12X mutants, however, show insensitivity to GAPs that accelerate hydrolysis [8].
Importantly, not only RAS G12X mutants exhibit a discrepancy in GTP hydrolysis, but they
also give rise to differences in the preferred signaling pathway (in terms of effector protein
binding) [9,10]. This behavior was first observed in NSCLC cell lines [9], where KRAS G12D
showed activation of PI3K and MEK signaling, while G12C and G12V mutants exhibited acti-
vated RalGDS-pathway and diminished growth factor-dependent Akt activation. Furthermore,
an NMR study revealed different binding preferences for mutant HRAS G12V compared to
wild-type HRAS, with various effector proteins [10]. Here, HRAS G12V showed reduced inter-
actions with Raf and enhanced binding with RalGDS. However, given that the non-hydrolysa-
ble GTP-analog GNP was used in the study, the difference is not due to impaired hydrolysis.
Similarly with HRAS, KRAS G12X mutants exhibit reduced affinity to Raf compared to wild-
type [8]. The G12D, G12R, and G12V mutants display highly reduced affinity to Raf, while the
affinity of G12A is only moderately reduced. Interestingly, the affinity of the G12C mutant is
similar to that of wild-type.
To bind RAS, the effector proteins use a ubiquitin (UB)-like fold: a RAS-binding domain
(RBD) or a RAS-association domain (RA) [11,12]. While KRAS has not been co-crystallized
with any of its effector proteins, distinct effector proteins have been resolved in complex with
HRAS: RalGDS (PDB ID: 4G0N) [13], Raf-1 (PDB ID: 1LFD) [14], PI3Kγ (PDB ID: 1HE8)
[15], PLCε (PDB ID: 2CL5) [16], RASSF5 (PDB ID: 3DDC) [17] and AF-6 (PDB ID: 6AMB)
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[18]. These effector proteins bind to HRAS on top of its switch regions: switch-I (residues 30–
40) and switch-II (residues 58–72), and the binding conformation of HRAS is almost identical
in all of the complexes (S1A Fig). Given this, and since the G12X mutation is far from the
binding interface (S1B Fig), Smith and Ikura [10] proposed that the discrepancies in the effec-
tor protein binding profiles of the mutants are due to altered switch dynamics. Overall, switch-
I displays highly dynamic characteristics manifested as two different states when GTP is
bound to RAS, and the distribution between these states is altered in mutants [19–22]. Given
that the switch regions in HRAS and KRAS are identical (S1C Fig), their expected binding
mode to their effectors is alike. A model of KRAS in complex with A-Raf-RBD tethered to a
lipid-bilayer nanodisc suggested by NMR data agrees with this binding mode [23]. At the cel-
lular level, the isoform specificity to effector proteins is primarily determined via membrane
interactions [24], but the differences among RAS isoforms’ absolute effector protein binding
affinities rise from allosteric effects [25]. It was observed that even a single point mutation in
RAS (Q61L) has long-range effects on dynamics and alters effector protein interactions [13].
Previous molecular dynamics (MD) simulation studies of KRAS at microsecond timescales
have mainly focused on the dynamical differences between the three wild-type RAS isoforms
(HRAS, KRAS, NRAS) [26], differences among selected KRAS and HRAS mutants [27,28], the
role of the hypervariable region (HVR) [29], KRAS’s membrane association or orientation
[30–32], and KRAS oligomerization on the membrane [33]. The total simulation times of
these studies were in the range of 1–8 μs, which is reasonable but likely not sufficient to unravel
long-time dynamics associated with slow conformational changes. More importantly, there is
a lack of comprehensive atomistic MD simulations of all KRAS G12X mutants with extensive
simulation times, allowing a reliable analysis for the differences in structure and dynamical
behavior between the wild-type and the mutants, especially in the effector protein binding
interface.
What is the underlying cause for the broad range of different G12X mutations? How do
these distinctly different mutations manifest themselves in the structure, dynamics, and func-
tion of KRAS? This knowledge is crucial to understand KRAS oncogenesis and to develop
future therapies targeting mutant KRAS harboring tumors. Therefore, in the present study we
first assessed to what extent G12X mutation frequencies are explained by mutation probability.
Intriguingly, an outstanding mutational bias emerged from the data. We next employed state-
of-the-art atomistic MD simulations (total simulation time 170 μs) to study the dynamical
behavior of KRAS with its natural ligands (GDP, GTP) bound, both in the wild-type KRAS
and with all existing oncogenic G12X mutations. The results provided compelling evidence
that mutations alter the dynamics of KRAS, that the alteration is mutation specific, displays
allosteric characteristics, and that the alteration is manifested especially in the effector protein-
binding interface. Furthermore, our data suggest that the observed mutational bias and the
oncogenic properties of the individual KRAS G12X mutants are caused, at least in part, by
mutation-specific altered dynamics.
Results
Distribution of KRAS G12X mutations is not random
First, to perceive up-to-date data of KRAS G12X missense mutation frequencies, we compiled
data from the Catalogue of Somatic Mutations in Cancer [2]. A total of 32,654 tumor samples
identified with a KRAS G12X missense mutation were found from the database. For our analy-
sis, we included only tissues that exhibited these mutations >10%. This status is displayed in
eight tissue types, which in total comprised 31,251 positive samples (95% of all KRAS G12X
mutations in the database). The large intestine (18,174), the lung (5,640), and the pancreas
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(5,528) were observed to have numerous positive samples, whereas the biliary tract, the endo-
metrium, the ovary, the peritoneum, and the small intestine comprised altogether only 2,085
positive samples.
A point mutation in KRAS G12X may result in one of six possible missense mutations (Fig
1J). However, instead of being evenly distributed, these specific mutations display considerable
variation (Fig 1A). Overall, G12D (42%), G12V (28%), and G12C (14%) mutations are very
common, whereas G12A, G12R, and G12S are less popular. When the relative fractions of
these mutations are considered in different tissues, they are readily observed to vary signifi-
cantly (Fig 1B–1I) [2]. For instance, the G12R mutation is observed in the pancreas with a
probability of 13%, while in the small intestine it appears in less than 2% of the cases. The pre-
dominating mutations are G12D and G12V, the lung being an exception with G12C standing
as the most abundant mutation.
In a G12X missense mutation, the guanine (G) base in c.34G or c.35G is substituted to ade-
nine (A), cytosine (C), or thymine (T) (Fig 1J). This base-substitution type exhibits variation
(Fig 1K). G>A and G>T mutations (47.4% and 42.1%, respectively) occur very often, while
the G>C mutation (10.5%) takes place more seldom. These occurrences display some varia-
tion in different tissues. Particularly the lung differs from other tissues with a higher G>T frac-
tion and a diminished proportion of G>A mutations (P< 0.001). Meanwhile, in the pancreas
the probability of the G>C mutation is increased (P< 0.001). Moreover, as all of the G12X
mutations occur in the first or the second guanine of the codon (c.34G, c.35G) (Fig 1J), we
ascertained if there is a mutational bias between these positions. Interestingly, 76.6% of the
G12X mutations are c.35G>X mutations (G12A, G12D, G12V) and only 23.4% are c.34G>X
mutations (G12C, G12R, G12S) (Fig 1L). In fact, all tissues, except for the lung (55.3%), display
77–90% of c.35G>X mutations. The positional mutation preference for c.35G>X seems to be
the highest with a G>A mutation (>7x), whereas G>C or G>T exhibit nearly twofold prefer-
ence, 1.75- and 2.03-fold, respectively (Fig 1M). A few exceptions in the c.35G>X preference,
however, appear in specific tissues. In the pancreas, the G>C mutation occurs nine times
more often in c.34 than in c.35 (Fig 1O). As for the G>T mutations, the lung is the only tissue
where c.34 is preferred (>1.5x) (Fig 1P). All tissues, interestingly, exhibit over fivefold c.35
preference in G>A mutations (Fig 1N). Above all, the pancreas (>28x), the peritoneum
(>37x) and the ovary (>41x) exhibit the most prominent preference for the G>A mutation in
c.35.
We evaluated how random the occurrences of the specific G12X mutations are. To this end,
we used the transition:transversion mutation ratio as a figure of merit, and compared this fig-
ure to a value of 2.3, which is the ratio for missense mutations observed in large-scale genomic
analyses [34,35]. If the mutations would take place randomly, G12D and G12S mutations
should be the most abundant mutations as they are transition mutations (S2 Fig). G12D muta-
tion is consistent with this view, as it occurs very often in all tissues. Meanwhile, G12S is not
consistent with this behavior at all, as it occurs in tumors, perhaps surprisingly, very rarely.
Also, regardless of the tissue type, the G12V mutation is overexpressed compared to values
expected based on the assumption of random occurrences. Concluding, the mutations’ proba-
bilities of occurrences are not consistent with a transition:transversion mutation ratio based
on a random process.
Since local DNA-sequences have clearly a major influence on the mutation probability, a
sequence-dependent basis for the observed non-random mutations may exist. The TGGT
sequence lacks a typical hotspot mutation region, such as a CpG site [36]. However, an adja-
cent GG region is a susceptible site for a mutation [37,38]. The oxidation of guanine by endog-
enous reactive oxygen species may also result in DNA mutation [39]. Both guanines, the 5’G
and the 3’G in a GGT-sequence, are found to act as sites for frequent one-electron oxidation
KRAS G12 missense mutants’ mutation probability and dynamics
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Fig 1. The occurrences of specific KRASG12X mutations vary among different tissues, and tissues exhibit individual preference in mutation type and
position. The occurrence of specific mutations in (A) all tissues, (B) the pancreas, (C) the large intestine, (D) the lung, (E) the peritoneum, (F) the small intestine,
(G) the biliary tract, (H) the endometrium, and (I) the ovary. Numbers shown in panels B-I indicate the numbers of observed positive tumor samples. In panels B-I,
the data are ordered from the highest occurrence (%) of a G12X mutation (panel B) to the lowest (panel I). Data have been collected from the COSMIC database [2]
v.79 (http://cancer.sanger.ac.uk/cosmic/). (J) KRAS G12X single point mutations occur if c.34 or c.35 is mutated. (K) Mutation types observed in all tissues, the
pancreas, the large intestine, and the lung. (L) Fraction of position c.35G mutations compared to all the mutations averaged over all tissues, and found in individual
tissues. (M) Positional mutation preference of specific mutation types in c.34 and c.35. (N-P) Position mutation preference characterized through c.35G over c.34G
in specific tissues with (N) G>A, (O) G>C, and (P) G>T mutations. Tissues with less than 50 positive samples (the peritoneum, the small intestine) have been
omitted from the panels O and P. Statistically significant differences in the panels K-M compared to other tissues or position are indicated with an asterisk, 
P<0.001; † = non-significant (Fischer exact test).
https://doi.org/10.1371/journal.pcbi.1006458.g001
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reactions, and they exhibit only a minor difference (0.05 eV) in their vertical ionization poten-
tial [37]. The oxidation can further transform guanine to 7,8-dihydro-8-oxoguanine (8oxoG),
which promotes especially the G>T transversion mutation [40], and the G>T mutations take
place on a regular basis (Fig 1K). Interestingly, studies of DNA-adduct formation by exoge-
nous agents have resulted in adduct formation only in c.34G, and not in c.35G [41,42]. Finally,
cigarette smoking promotes G12C mutations exhibited regularly in the lung tissue (Fig 1D and
1K) [7]. Concluding, there are several potential mechanisms able to alter the mutation profile
of guanine, thereby leading to the data we discussed above.
Atomistic molecular dynamics simulations reveal that the switch regions in
KRAS are highly mobile
To understand how G12X mutations affect KRAS functionality, we conducted a total of 170 μs
(85 x 2 μs) atomistic MD simulations of wild-type KRAS and all G12X missense mutants, with
GDP and GTP. Each individual system was replicated five to ten times starting from different
initial conditions (S1 Table).
In the simulations, we observed no differences in the dynamics of the residue 12 (or in its
vicinity), which appeared to be extremely stable. In contrast, the switch regions (switch-I and
switch-II) exhibited highly dynamic behavior demonstrated by the root-mean-square fluctua-
tion (RMSF) analysis, which revealed major fluctuations in the protein in these regions (S3
and S4 Figs). Nevertheless, there were no evident differences between the different systems, as
generally the individual replicas displayed variation as much as the different systems. Only
with GDP, the G12A and the G12S display a different RMSF profile in the switch-I region.
The bound ligands GDP and GTP affect KRAS dynamics
To gain better insight into the protein dynamics, we conducted principal component analysis
(PCA) [43] with an objective to find the most significant large-scale motions of KRAS. PCA
revealed that the greatest dynamic movements in the protein occur in the switch regions (Fig
2, S5A Fig). Furthermore, the most significant principal components 1–3 (PC1-3, see S5B Fig
for contributions) highlight that there are strong differences between GDP-bound and GTP-
bound systems. PC1 of the GTP-bound systems displayed movement only in the switch
regions, whereas PC1 of the GDP-bound systems exhibited additional movement also in the
α3-helix. PC2 of GDP-bound KRAS revealed the movement in the switch regions and also
extensive motion in the α3-helix, the hairpin loop between the β2- and β3-sheets, and the P-
loop (see S1D Fig). PC2 of GTP-bound KRAS in turn brought out the movements observed in
GDP-bound systems, and further also the motion in the α1- and α4-helices, and in the turn
near the SAK-motif. These observations indicate that the key to resolve the changes in protein
dynamics is the γ-phosphate.
Notably, the α4-helix motion is only observed with GTP bound systems (PC2). This obser-
vation is in agreement with the experimental results by Mazhab-Jafari et al. [23]. They
observed that the GDP-bound KRAS drives the protein in the “exposed” configuration on the
membrane, where the α4-helix is located in close proximity to the membrane (PDB ID:
2MSC). This would indicate that the dynamical stability of the helix is important for this state.
Individual mutants display unique dynamics
In order to ascertain dissimilarities between the different systems, we next generated score
plots for the principal components PC1-3 (Fig 3, S5C and S5D Fig). The results highlight dis-
similarities between the wild-type KRAS and the mutants, as well as between GDP- and GTP-
bound proteins. Interestingly, in all of these systems, only the G12R and G12S mutants with
KRAS G12 missense mutants’ mutation probability and dynamics
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GDP appear to reside in the closed switch-I conformation, whereas all other systems eluded
this conformation. Even more interestingly, both of these mutants evaded this conformation
when they were bound to GTP. The fully open conformation of switch-I appears to be more
accessible to the systems, especially with the G12D mutant with GDP. Moreover, wild-type in
both GDP- and GTP-bound systems seems to have a unique state with a high-scoring value
(+3 and +4) in PC1 and a low-scoring value (-2 and -0.5) in PC2. Taken together, the results
show for all the mutants that the profile of their large-scale motions differs from wild-type
regardless of the bound ligand, and that the profile is also unique to each mutant.
We extended the analysis by carrying out PCA for each system to illustrate the differences
in their dynamics (S6–S9 Figs). The individual PCA analyses highlight not just variation in the
switch region movements among the systems, but they also show that specific systems display
more dynamical behavior in the α3-helix, hairpin loop between the β2- and β3-sheets, the
α4-helix, the loop between β5-sheet and α4-helix, and in the SAK-motif (residues 145–147)
regions. For example, in GTP-bound systems only the G12A, G12D, G12R, and G12V mutants
exhibited movement in the α4-helix in their PC1 or PC2. Interestingly, these are also the sys-
tems that exhibit clearly diminished Raf affinity [8]. Also, the G12R mutant with GTP dis-
played notably reduced movement in the switch-II region in both PC1 and PC2.
Hydrophobic hubs form an allosteric interaction network throughout
KRAS
Even though there are no additional direct interactions from the mutated side-chains of G12X,
a mutation in this position inflicts a change to the dynamics in the distant sites of KRAS that
were highlighted by the PCA analysis. To investigate this, and to identify possible interaction
network routes in KRAS, we conducted an interaction network analysis [44]. Interestingly, we
Fig 2. GDP- and GTP-bound systems exhibit distinctly different dynamics. The extreme movements of the principal components PC1 and PC2 in all (A, B) GDP
systems and (C, D) GTP systems. Color coding: residue 12 (orange), switch-I (residues 30–40, red), and switch-II (residues 58–72, blue).
https://doi.org/10.1371/journal.pcbi.1006458.g002
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Fig 3. Dynamics of the mutants characterized by their principal components display individual profiles. PCA (backbone) score plots (heat map) of (A) GDP-bound
and (B) and GTP-bound systems. Top-left boxes comprise all the systems with (A) GDP or (B) GTP. For conformational reference, the backbone conformation of RAS
from the RAS–effector and RAS–GEF complexes is included in the plots, where switch-I and switch-II are in a totally closed conformation (blue crosses; from RAS–
effector protein complexes) or switch-I is in a fully open conformation (cyan crosses; from a RAS–GEF complex). Reference RAS structures were obtained from HRAS–
effector protein complexes (PDB IDs: 1HE8, 1LFD, 4G0N) and from the HRAS–Sos complex (PDB ID: 4NYJ).
https://doi.org/10.1371/journal.pcbi.1006458.g003
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identified a hydrophobic hub network in KRAS that indeed connects the distant sites in the
structure and is able to convey these effects in an allosteric way (Fig 4). Therefore, a change in
KRAS dynamics in one of the hydrophobic hubs could traverse through this network even to
the distant sites. This hub network is comprised of 11 hubs: V14, M72, F78, L79, F90, I100,
V114, A146, A155, F156 and L159. One of these hubs, V14, is located in the P-loop, in the
close proximity of G12X.
This hub interaction network is highly distorted in G12A and G12S mutants (S10 and S11
Figs). The distortion in these mutants is further not ligand dependent. For example, in the V14
hub, the G12A and G12S mutants lack the interaction to A81 (<2% vs. wild-type 26.9% and
39.7%, with GDP and GTP, respectively), and also display highly diminished interaction to
A11 compared to the wild-type KRAS (S10A Fig). From the V114 hub, these mutants lack
interactions to A155 and L79, but instead have a strengthened interaction to I142 and a totally
new interaction to L113, which is not displayed by other systems (S11A Fig). From the hub
A146, they lack the interactions to A18 and L19 (S11B Fig). From the hub A155, both lack the
interactions to V114, L79, and I142, but instead they have an elevated interaction to F156, and
the G12A has an additional interaction to V152 (S11C Fig).
In contrast to G12A and G12S, the other mutants (G12C, G12D, G12R, and G12V) seem to
follow more closely the wild-type’s interaction patterns. However, selected interactions are
shifted even with these mutants, although not that extensively as observed with G12A and
G12S. For instance, in the hub M72 located in the switch-II region the interaction patterns are
shifted with G12C, G12R, and G12V (S10B Fig). Interestingly, the GTP-bound G12D mutant
displays almost identical interactions with the wild-type.
Fig 4. The hydrophobic interaction network of KRAS. The interaction network is represented for the GTP-bound wild-type KRAS (A), where
hydrophobic hubs are displayed as large teal spheres (except for M72 depicted as blue). The hubs are defined by the criteria that each hub displays at
least three hydrophobic contacts (>10%). The hydrophobic interactions (>10%) are depicted with cylinders, where the frequency of interaction is
depicted in a scale from blue and thin to red and thick for low and high frequencies, respectively. The hydrophobic residues connected to the
network that can influence the switch-I and switch-II dynamics are shown in small red and blue spheres, respectively. Moreover, the hub M72 is
directly part of switch-II (large blue sphere). The salt-bridge forming residues D154 and R161 are displayed as green sticks. In the 2D representation
of the hydrophobic hub network (B), the hydrophobic interactions (>10%) are shown with lines, and in addition to the hubs (spheres) all the
hydrophobic interacting residues to the hub network are shown (in GTP-bound wild-type). The P-loop is indicated with a dashed line.
https://doi.org/10.1371/journal.pcbi.1006458.g004
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We also noticed that the frequency of the salt-bridge between the residues D154–R161 was
altered in different systems (S11F Fig). Both of these residues are located in the α5-helix, in the
close proximity of three hydrophobic hubs: A155, F156 and L159 (Fig 4). With the wild-type
KRAS this salt-bridge is more stable with GDP (69.1%) than with GTP (46.4%). Meanwhile,
again with the G12A and G12S mutants this salt-bridge is highly distorted (4.5%–20.6%),
regardless of the bound ligand.
Markov state models confirm altered dynamics in selected mutants and
reveal specific metastable state distributions
As discussed above, the PCA and the interaction network analysis suggest that the protein
dynamics is altered among the systems, yet in some obscure manner. To gain better insight
into the origin of these differences in wild-type and mutant GTP-bound systems (active
KRAS), we analyzed the simulation data by constructing Markov state models (MSMs) [45,46]
to explore the long-time statistical conformational dynamics of KRAS. The goal here was to
identify the clusters of highly identical protein conformational states, here called metastable
states, and to explore how the conformations of the wild-type and the mutant proteins are dis-
tributed between these metastable states. For the analysis, we selected the wild-type KRAS
together with the most abundant mutants G12D and G12V, and the intriguing G12R mutant,
which displays a highly variable distribution in the different tissues (Fig 1).
The MSM analysis identified seven metastable states represented schematically in Fig 5.
Overall, all systems populate frequently two of the states: the states VI and VII (77–87%). The
less populated metastable states I-IV are specifically represented among the systems. The meta-
stable state I is quite unique for G12R (6%) and the state III for G12V (6%), whereas the other
systems are mostly absent from these two states. The metastable state IV is only present in
wild-type (3%) and in the G12V mutant (3%). The moderately populated metastable state V,
where switch-II appears in a fixed conformation, is rarely observed with the G12V mutant
(1%), whereas it is similarly represented among the other mutants and the wild-type (12–
16%). In fact, the switch-II conformation appears to be closed in the effector protein com-
plexes (S1A Fig). However, none of the observed metastable states corresponds to this specific
switch-II binding end-point conformation.
The states can be further divided in four groups based on their switch conformations
(Table 1). The states I and V as combined form the first group, where switch-I appears to be in
a fully open conformation and switch-II in a fixed conformation. This group is frequently
occupied by G12R (24%), whereas it is mostly absent from G12V (1%). The states VII and VI
form individually the second and the third groups, in respective order. In the state VII, switch-
II is in a fixed conformation and switch-I is more closed compared to the first group. This
group is more frequently populated by G12R. In the state VI, switch-I is open and switch-II is
in a mixed conformation between the fixed and perpendicular conformations. This state is
clearly less populated by G12R compared to the other systems. The fourth group, where the
switches appear in a perpendicular conformation, is frequent with G12V (12%), whereas the
other mutants rarely visit this state (1%).
Of all the mutants, G12D displays the most similar metastable state population distribution
compared to wild-type (Fig 5, Table 1). This is most evident in the most populated states (states
IV, VI, and VII), yet G12D also differs from wild-type in the less populated states (I–IV). In
contrast, the conformations of G12R are clearly shifted towards the fixed switch-II states,
whereas G12V is shifted away from these states towards the perpendicular states. The results
suggest that for G12V the shift among the states is due to the mutant’s lipophilic character,
which may cause changes in solvent organization preventing specific switch-II conformations.
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Finally, it is exceptional that while wild-type does not populate the metastable states I and III
at all, there are mutants (G12R, G12V) whose population in these states is significant (about
Fig 5. The seven metastable states identified by the Markov state model. In the middle is the time-lagged independent component analysis (TICA) plot showing
seven clusters, each of which corresponds to one metastable state (I–VII). The metastable states are classified by borderlines, and the “microstates” (dots) in each
metastable state are colored with the same color. The seven boxes around the middle describe the seven metastable states found in the MSM analysis, each
box illustrating three representative protein conformations (generated using MSM), which identify the residue 12 (orange), and also the switch-I (red) and switch-II
(blue) regions depicted by their backbone’s molecular surface (dots). In each metastable state, the occupation percentage by wild-type and individual mutants is
displayed next to the conformations. For each case (wild-type, G12D, G12V, G12R), normalization of the percentages is done such that the sum over the seven
metastable states adds up to 100%.
https://doi.org/10.1371/journal.pcbi.1006458.g005
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6%). This summarizes the main message: the conformation distribution of KRAS mutants
includes conformations not occupied by wild-type, and these conformations are also mutation
specific.
Discussion
Although frequently observed in cancer, not only is the basis for the specific frequencies of
KRAS G12X mutations poorly understood [47], but also the effects of these specific mutations
on a molecular scale are not clear. To the best of our knowledge, this is the first study to assess
KRAS G12X mutation probabilities, and to understand how they are associated with the
observed mutation frequencies.
Generally, the mutation frequencies have an explanatory basis. For instance, chemical char-
acteristics of c.35G explain the enrichment of the G12V mutations by oxidation. However,
complex mutation distributions are displayed by the tissues, and we conclude that some of the
observed frequencies cannot be explained simply by the mutation probability. For example,
there is no clear explanation why, on average, a mutation occurs five times more probably in,
e.g., c.35G than in c.34G. One plausible explanation is that the 3D-environment in the DNA-
sequence may aid the c.35G mutations to evade DNA-repair mechanisms. In fact, the struc-
tures of DNA in complex with N-glycosylase/DNA lyase (OGG1), which is a base-excision
repair enzyme for 8oxoG, exist in a catalytically active form for 8oxoG that is adjacent to gua-
nine only in the 5’-position in -AGGT- sequences (S12 Fig) [40,48–51]. Correspondingly, this
5’G position in the KRAS sequence (-TGGT-) represents the c.34G position, thus suggesting
that the c.34G position is more susceptible for DNA-repair. Nevertheless, this observation
holds true only for the G>T transversion mutation. For the other mutations and their repair
mechanisms, the positional bias needs to be investigated, especially for the G>A transition
mutation, which holds the strongest bias in favor of c.35G mutations (>5x in all tissues). Fur-
thermore, exceptions or an enhanced preference in c.35G for specific mutations in particular
tissues were observed. For instance, it seems that either the advantage for G12D or the disad-
vantage for G12S, or both, exists in the pancreas, given that there is a 28-fold preference for
G>A mutations for c.35G over c.34G. Similarly, the G12R mutation displays an advantage in
the pancreas, while G12A is perhaps disadvantageous, given that there is a 9-fold preference
for c.34G over c.35G in the mutation probability in the G>C mutations. Altogether, these data
suggest that specific mutations are advantageous or disadvantageous depending on the cellular
and tissue environments. Therefore, we hypothesize that the biochemical and biophysical dif-
ferences among mutants, resulting in signal-transducing differences, may explain, at least in
part, the observed mutational bias.
To gain insight into these observed discrepancies among the mutants on a molecular level,
we carried out a comprehensive all-atom MD simulation study of all KRAS G12X missense
mutants. We found that mutations have a profound effect on the dynamics of KRAS. In partic-
ular, we observed that the switches are highly dynamic. This conformational flexibility revealed
through atomistic simulations is consistent with 31P-NMR spectroscopy studies of RAS
Table 1. Distribution of conformational groups.
Group Switch-I / Switch-II conformation States G12D G12R G12V WT
1 Fully open / fixed I, V 14% 24% 1% 13%
2 Semi-open / fixed VII 52% 60% 55% 54%
3 Open / mixed VI 33% 17% 32% 29%
4 Perpendicular II, III, IV 1% 1% 12% 4%
https://doi.org/10.1371/journal.pcbi.1006458.t001
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proteins [21,52], while the published KRAS crystal structures do not unlock this behavior.
Even in our extensive analysis of the long-timescale simulation data the differences in the
dynamics were not readily visible. This is not surprising given that even though the binding
affinity of a specific mutant toward an effector protein is increased or diminished, the ability
to bind still exists [8]. This suggests that the changes in protein dynamics are quite subtle and
difficult to quantify. In our work, we unlocked this issue through the analysis of the simulation
data using PCA, interaction network analysis and MSMs that indeed revealed the differences,
not only between the wild-type and the mutants, but also between the mutants.
In order to capture the subtle differences among the mutants, we kept our MD simulation
systems realistic but sufficiently simple, enabling the extended simulation times close to 200 μs
in total. Even though the HVR and the cell membrane were absent from our simulations, we
recognize that these elements have a substantial influence on KRAS dynamics [53,54] and sig-
naling [55]. We therefore cannot deduce whether some of the observed mutational effects
attenuate or amplify through these factors. However, effects related to the cell membrane
remain to be explored in follow-up studies.
Importantly, we identified the hydrophobic hub interaction network that is able to convey
the shifts in KRAS dynamics throughout the whole structure in an allosteric manner. The crys-
tal structures of KRAS G12X mutants display only minor differences, but the lack of structural
differences does not exclude the allosteric effect of the mutation [56]. The shift in the dynamics
by G12X is able to occur via the closest hydrophobic hub V14. As the wild-type KRAS has a
flexible glycine residue in this position, a G12X mutation alters the dynamics of the neighbor-
ing residue A11 or the whole P-loop (including both A11 and V14). As this hydrophobic hub
V14 is connected to a hydrophobic network, a local alteration in KRAS dynamics can be con-
veyed via the hydrophobic network to the other remote structural regions in KRAS in an allo-
steric manner.
Supporting the fact that V14 is an important hub in the KRAS hydrophobic interaction net-
work, a mutation in this position, V14I, is found to be one of the responsible mutations for the
Noonan syndrome [57,58] and may also predispose tumor development [59]. Whereas the
V14I mutation does not change the GTPase activity of KRAS, it displays similar affinity to
RAF1, as does also the G12V mutant [60]. Therefore, a mutation that has an influence in the
dynamics of these hydrophobic hub interactions may have a dramatic influence in overall
KRAS dynamics and thereby KRAS signaling.
The most altered interaction pattern within the hydrophobic interaction network in all the
hubs is observed with the G12A and G12S mutants. Surprisingly, the other mutations (G12C,
G12D, G12R and G12V) are not radically different compared to the wild-type, although some
alterations in the hub interactions are evident. However, even though a mutant, such as G12D,
displays the same interaction frequencies as the wild-type, the characteristics of the interac-
tions may still differ, as the exact characteristics of these interactions, unfortunately, cannot be
derived from this analysis, only their frequencies.
To highlight that the alteration in KRAS dynamics is also present with the mutants that dis-
play a minor shift in the hydrophobic hub interaction network compared to the wild-type, is
the observed variability in the distribution among the metastable states of exceptional impor-
tance. The MSM confirmed the indirect effect of the mutation on the switch-region protein
conformations and dynamics. As for MSMs one needs to have extended simulation data, we
focused on the most important KRAS G12X mutants (G12D, G12R and G12V). In crystal
structures these dynamic metastable states are not observed. This is due to the fact that in the
structures the switch regions are disordered, if there are no crystal contacts to the switches.
Based on the MSMs, the G12D mutant follows the dynamics of the wild-type more closely
than of the G12R and G12V mutants. Intriguingly, this is in line with the findings of the
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interaction network analysis, where the G12D displayed the most similar profile with the wild-
type. In particular, our MD results show that the effects of KRAS G12X mutants are mutation-
specific, and suggest that the observed changes in protein conformations and dynamics may
alter protein activity [61].
We consider that the difference in the mutant dynamics, for instance the G12V dynamics
with its inability to reach the metastable states I and V (Fig 5), may reflect the differences
observed in the RAS effector protein binding [8,10]. In fact, simple protein complexes assem-
ble generally via a single pathway [62], and the observed metastable states may correspond to
the first steps in the effector protein binding process. These states may be important for spe-
cific effector protein binding and pathway activation. However, based on the simulation data
we were unable to distinguish if a putative effector protein(s) or a particular signaling pathway
(s) is related to a specific metastable state. It needs to be clarified, if these states act as interme-
diate steps in the KRAS–effector protein association and play a role in the macromolecular
recognition process, effecting the association kinetics of the complex formation [63]. Further-
more, multiple other aspects related to the altered dynamics may also affect KRAS mediated
signaling. The altered dynamics may cause a conformational change of KRAS on the mem-
brane, resulting in occluded conformation from a specific effector [23], alter the dimer forma-
tion [64], or affect KRAS nanoclustering [65]. Furthermore, the altered dynamics may affect
the stability of a KRAS–effector complex itself that may lead to a more stable complex, result-
ing in binding with a longer lifetime, or conversely to a more unstable complex, resulting in
faster dissociation. Altogether, this implies that the altered protein dynamics has an influence
on the KRAS binding partner selection.
As a crucial factor for KRAS dimerization, the intermolecular D154–R161 salt-bridges
between the dimers were recently identified [66]. The KRAS dimerization is a GTP-dependent
process [67]. Here we observed that with the GTP-bound wild-type, there is a shift in the
dynamics of the putative α4-α5 dimer interface region, manifested by the more unstable intra-
molecular D154–R161 salt-bridge. This suggests that the more stable intramolecular salt-
bridge within the monomer residues could hinder the dimer formation in GDP-bound KRAS,
whereas due to the change in the dynamics on the site in GTP-bound KRAS, the more unstable
intramolecular salt-bridge could promote the formation of intermolecular salt-bridges among
these residues, and thus dimer formation. This intramolecular salt-bridge is again, regardless
of the bound ligand, heavily distorted with the G12A and G12S mutants that have a major
effect on the hydrophobic interaction networks.
In general, the mutational frequency data combined with the observation from the simula-
tions suggest that at least in the pancreatic cancer, where a KRAS mutation is a key initiator
[68], a major shift in KRAS dynamics is not tolerated. This fact is manifested by the low fre-
quencies of G12A and G12S mutants in the pancreas. Moreover, the distorted dynamics could
also offer an explanation why the G12S mutant is rarely observed even though it is a transition
mutation.
It has been clearly shown that the KRAS G12X mutation has an effect on the intrinsic
GTPase activity and that it causes insensitivity for GAPs. However, it seems that the interpreta-
tion of the mutation effect on the oncoprotein’s behavior has been oversimplified. First, in spe-
cific tissues G12X mutation frequencies exhibit an inexplicable individual bias. Furthermore,
the mutation inflicts individual changes in the protein dynamics, affecting the allosteric com-
munication network that conveys the shift in dynamics to the remote sites within KRAS.
Finally, this shift in protein dynamics may lead to modulated KRAS mediated signal transduc-
tion. We therefore suggest that altered dynamics among KRAS G12X mutants may promote
the observed non-random frequencies in specific tissues. In order to establish successful thera-
pies against mutant KRAS-harboring tumors, these discrepancies between the G12X mutants
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need to be reconsidered thoroughly. Concluding, KRAS G12X mutants are not equal, they are
unique.
Materials and methods
Atomistic models and molecular dynamics simulations
The simulations were conducted using the GROMACS package v. 4.6 with the (all-atom) OPL-
S-AA force field [69–72]. For the simulations, a high resolution (1.24 Å) truncated (169/188
residues) GDP-bound wild-type KRAS structure (PDB ID: 4OBE) [73] was selected, where
most of the HVR is absent (see S1 Fig). Mutant KRAS structures were generated from the
wild-type structure using Maestro [74]. For GTP-systems the GDP was replaced with GTP. As
a model for GDP and GTP ligands, the default OPLS-AA parameter set was used and the
geometry optimization for GDP and GTP was conducted with Gaussian [75], using the Har-
tree-Fock method and the 6–31+G basis set. The partial charges for both ligands were
derived from the electrostatic potential by performing a RESP fitting procedure with R.E.D.
Tools IV [76,77]. Co-crystallized water molecules from the crystal structure were hold intact,
with an exception of GTP-systems with one water molecule, which occupied the γ-phosphate
binding position to Mg2+. Water molecules were described with the TIP3P model [78]. In each
system, the protein was solvated in a cubic box (edges at least 1.3 nm from the protein), and
the system was neutralized using a physiological ion concentration (140 mM) of K+ and Cl-
ions. After energy minimization, the system preparation was done in four stages to obtain
properly equilibrated and different initial structures for replica simulations (see S1 Table for
details). The simulations were performed with periodic boundary conditions in the NpT
ensemble. The V-rescale and Parrinello-Rahman methods were used for temperature (310 K)
and pressure (1 atm) coupling, respectively [79,80]. The default 2 fs time step was used for inte-
gration of equations of motion. To preserve the length of all bonds, the LINCS algorithm was
used [81]. For Lennard-Jones interactions and the real-space part of the particle mesh Ewald
electrostatics, a cutoff of 1.0 nm was used [82]. Each system was simulated for 2 μs with 5–10
independent replicas, such that the individual system simulation time was 10–20 μs and the
total simulation time was 170 μs.
Analysis of simulation data
The RMSF were calculated using GROMACS tools [69]. Principal component analysis (PCA)
was conducted for the backbone atoms by the GROMACS covariance analysis tools. For PCA,
we discarded the first 300 ns and used only the last 1.7 μs of each simulated system, to remove
the potential bias of the starting GDP crystal structure from the results. To reduce noise from
the flexible terminal regions, we excluded from the analysis the first three residues from the N-
terminal and the last five residues from the C-terminal. The PCA structures (Fig 2, S5–S9 Figs)
were obtained utilizing the GROMACS tool gmx_anaeig, and visualized with PyMOL 1.8 [83]
using a pymol-script Modevectors [84].
The analysis of KRAS interaction networks (the hydrophobic clusters and the salt-bridges)
was conducted with PyInteraph [44] and visualized with PyMOL [83]. This analysis was con-
ducted for full trajectories and all residues were included in the analysis.
Markov state model generation was conducted with PyEMMA 2, following the general rec-
ommendations [46]. As an input, we used distances between the residues 12, 32, 34, 36, 48, 59,
62, 64, 67, 105, 122, 126, and 138 from the simulation trajectories. We selected these residues
based on their functional importance in KRAS (location in the interaction surface with the
effector proteins), the results of PCA (dynamical importance), or both. Furthermore, a slow
linear subspace from this input was estimated by TICA [85], as TICA highlights the slowest
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motions from simulations and is highly suitable for generation of a MSM [86], using 40 ns as a
lag-time, and two dimensions. Furthermore, the output of TICA was clustered using the k-
means clustering, and the discretized trajectories from the clustering analysis were used to gen-
erate the BayesianMSM. The number of clusters in k-means were set as
p
N, as recommended
in [46]. The microstates were grouped in seven metastable states by the Perron-cluster cluster
analysis (PCCA++) method [87], based on the spectral analysis (S13C Fig). The generated
models were validated by two methods. First, we calculated the resulting timescales and found
that the timescales were constant in the used 40 ns lag-time (S13–S15 Figs). Furthermore, we
conducted the Chapman-Kolmogorov test, which displayed that the model followed the
expected estimates. The occupations of individual mutants in each metastable state (Fig 5)
were computed from their individual Markov models.
Statistical analyses of mutation frequencies
The KRAS G12X mutation data was collected from COSMIC database v.79 (http://cancer.
sanger.ac.uk/cosmic/) [2]. In our assessment of the KRAS G12X mutation probability, we
included only single nucleotide substitutions. This choice was made based on the fact that
more complex mutations and their probabilities (e.g., adjacent double substitutions) are not
predictable with the existing knowledge. Fisher’s exact test was used to analyze the specific dif-
ferences in mutation frequencies.
Supporting information
S1 Fig. (A) Regardless of the bound effector protein, the RAS conformation in the HRAS–
effector protein complexes remain identical. The superposed RAS structures have been taken
from RAS-complexes as follows: RalGDS (PDB ID 4G0N), Raf-1 (PDB ID 1LFD) and PI3Kγ
(PDB ID 1HE8). Highlighted in the figure are the switch-I (red) and switch-II (blue) regions,
residue 12 (orange), and GNP-ligand (cyan ball and sticks). (B) The effector proteins bind
RAS on top of the switch regions, indicating no direct contact between residue 12 (orange)
and effector proteins. Shown is the RAS–PI3Kγ complex (PDB ID 1HE8), with PI3Kγ identi-
fied (teal surface). The RAS surface is colored as in panel A, and GNP represented as CPK. (C)
The effector protein-binding interface is identical with HRAS and KRAS. The hypervariable
region (yellow) is not present in crystal structures (A and B). (D) The locations of the second-
ary structural elements in KRAS. Also, the positions of the Cα of residue 12 (cyan sphere), P-
loop (cyan), γ-phosphate of the GTP (ball & stick), and the SAK-motif (black) are highlighted.
(TIF)
S2 Fig. (A) Distributions of KRAS G12X mutations calculated based on an assumption of ran-
dom events dictated by a value of 2.3 for the transition:transversion ratio. The occurrence of
mutations related to random mutation frequencies in (B) all tissues, (C) the pancreas, (D) the
large intestine, (E) the lung, (F) the peritoneum, (G) the small intestine, (H) the biliary tract,
(I) the endometrium, and (j) the ovary. Individual tissues (B-J) have been arranged in decreas-
ing significance for the overall G12X mutation frequency (%), B displaying the highest and J
the lowest. Mutation data have been collected from the COSMIC database v.79.
(TIF)
S3 Fig. Root-mean-square fluctuation (RMSF) of GDP-bound systems: (A) G12A, (B) G12C,
(C) G12D, (D) G12R, (E) G12S, (F) G12V, and (G) wild-type. Error bars indicate the standard
error (SE). The average of all GDP-bound systems is indicated with an orange line. RMSF has
been calculated over a period of 300–2000 ns, with switch-I (residues 30–40) and switch-II
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(residues 58–72) identified as given here.
(TIF)
S4 Fig. Root-mean-square fluctuation (RMSF) of GTP-bound systems: (A) G12A, (B) G12C,
(C) G12D, (D) G12R, (E) G12S, (F) G12V, and (G) wild-type. Error bars indicate the standard
error (SE). The average of all GDP-bound systems is indicated with an orange line. RMSF has
been calculated over a period of 300–2000 ns, with switch-I (residues 30–40) and switch-II
(residues 58–72) identified as given here.
(TIF)
S5 Fig. Extreme movements of principal component 3 (PC3) given by PCA in (A) all GDP-
and GTP-bound systems. (B) The contributions (%) of principal components 1–10
(PC1-PC10). PCA3 vs. PC1 score plots (heat map) of (C) GDP-bound and (D) and GTP-
bound systems. Top-left boxes comprise all the systems with (C) GDP or (D) GTP. For confor-
mational reference, the backbone conformation of RAS from the RAS–effector and RAS–GEF
complexes is included in the plots, where switch-I and switch-II are in a totally closed confor-
mation (blue crosses; from RAS–effector protein complexes) or switch-I is in a fully open con-
formation (cyan crosses; from a RAS–GEF complex). Reference RAS structures were obtained
from HRAS–effector protein complexes (PDB IDs: 1HE8, 1LFD, 4G0N) and from the HRAS–
Sos complex (PDB ID: 4NYJ).
(TIF)
S6 Fig. Extreme movements of principal component 1 (PC1) given by PCA in (A) all GDP-
bound systems, and in individual GDP-bound systems: (B) G12A, (C) G12C, (D) G12D, (E)
G12R, (F) G12S, (G) G12V, and (H) wild-type. Highlighted regions are position of G12X
(orange), switch-I (red), and switch-II (blue).
(TIF)
S7 Fig. Extreme movements of principal component 2 (PC2) given by PCA in (A) all GDP-
bound systems, and in individual GDP-bound systems: (B) G12A, (C) G12C, (D) G12D, (E)
G12R, (F) G12S, (G) G12V, and (H) wild-type. Highlighted regions are position of G12X
(orange), switch-I (red), and switch-II (blue).
(TIF)
S8 Fig. Extreme movements of principal component 1 (PC1) given by PCA in (A) all GTP-
bound systems, and in individual GTP-bound systems: (B) G12A, (C) G12C, (D) G12D, (E)
G12R, (F) G12S, (G) G12V, and (H) wild-type. Highlighted regions are position of G12X
(orange), switch-I (red), and switch-II (blue).
(TIF)
S9 Fig. Extreme movements of principal component 2 (PC2) given by PCA in (A) all GTP-
bound systems, and in individual GTP-bound systems: (B) G12A, (C) G12C, (D) G12D, (E)
G12R, (F) G12S, (G) G12V, and (H) wild-type. Highlighted regions are position of G12X
(orange), switch-I (red), and switch-II (blue).
(TIF)
S10 Fig. Hydrophobic hub interactions in individual systems. Hydrophobic interactions
and their frequencies from hubs: (A) V14, (B) M72, (C) F78, (D) L79, (E) F90, and (F) I100.
The hydrophobic interactions that are present (>10%) at least in one system are shown.
(TIF)
S11 Fig. Hydrophobic hub interactions and D154-R161 salt-bridge in individual systems.
Hydrophobic interactions and their frequencies from hubs: (A) V114, (B) A146, (C) A155, (D)
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F156, and (E) L159. The hydrophobic interactions that are present (>10%) at least in one sys-
tem are shown. (F) The intramolecular salt-bridge D154-R161 frequency.
(TIF)
S12 Fig. Example of 8oxoG-DNA in complex with N-glycosylase/DNA lyase (OGG1). The
8oxoG is oriented inside the catalytic site of N-glycosylase/DNA lyase enzyme. PDB ID:
2NOB.
(TIF)
S13 Fig. Validation of Markov state model. (A) The resulting timescales are constant with
the used lag-time 40 ns. (B) The Chapman-Kolmogorov test shows that MSM (black line) fol-
lows the observed trajectory (blue dotted line, with estimate error). (C) The spectral analysis
revealed large timescale separation between the third and fourth, and sixth and seventh relaxa-
tion timescales.
(TIF)
S14 Fig. Validation of Markov state model for each system. The resulting timescales are con-
stant with the used lag-time 40 ns for individual MSMs: (A) G12D, (B) G12R, (C) G12V, and
(D) wild-type.
(TIF)
S15 Fig. The Chapman-Kolmogorov test for individual systems’ MSMs with the first six states:
(A) G12D, (B) G12R, (C) G12V, and (D) wild-type. Shown are data for MSM (black line) and
the observed trajectory (blue dotted line, with estimated error).
(TIF)
S1 Table. List of simulation systems showing their simulation times, number of repeats
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